HealthEquity (NASDAQ:HQY – Get Rating) will issue its quarterly earnings data after the market closes on Monday, June 6th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. HealthEquity has set its FY 2023 guidance at $1.210-$1.300 EPS and its FY23 guidance at $1.21-1.30 EPS.Parties that wish to listen to the company’s conference call can do so using this link.
HealthEquity (NASDAQ:HQY – Get Rating) last issued its quarterly earnings results on Tuesday, March 22nd. The company reported $0.09 EPS for the quarter, meeting analysts’ consensus estimates of $0.09. HealthEquity had a positive return on equity of 3.49% and a negative net margin of 5.85%. The firm had revenue of $203.30 million for the quarter, compared to analysts’ expectations of $199.27 million. During the same quarter in the prior year, the firm earned $0.30 EPS. On average, analysts expect HealthEquity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Shares of NASDAQ HQY opened at $62.80 on Monday. HealthEquity has a one year low of $36.81 and a one year high of $84.78. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.29 and a quick ratio of 2.29. The business’s fifty day moving average price is $63.51 and its 200-day moving average price is $56.05. The stock has a market capitalization of $5.30 billion, a PE ratio of -118.49, a P/E/G ratio of 5.45 and a beta of 1.08.
HQY has been the topic of a number of recent research reports. Zacks Investment Research raised HealthEquity from a “strong sell” rating to a “buy” rating and set a $58.00 price target on the stock in a research report on Tuesday, February 8th. TheStreet raised HealthEquity from a “d+” rating to a “c-” rating in a research report on Wednesday, April 6th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $62.00 to $66.00 and gave the company a “buy” rating in a research note on Thursday, March 24th. StockNews.com lowered HealthEquity from a “hold” rating to a “sell” rating in a research note on Sunday, March 27th. Finally, Bank of America boosted their price objective on HealthEquity from $63.00 to $70.00 in a research note on Wednesday, March 23rd. One equities research analyst has rated the stock with a sell rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, HealthEquity currently has a consensus rating of “Buy” and a consensus price target of $76.71.
HealthEquity Company Profile (Get Rating)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.